Werewolf cancer drug strikes right note with Jazz Pharma, sparking licensing deal April 7, 2022 Auto Bot BioPharma, biopharma nl, cancer, cancer immunotherapy, Clinical Trials, Dublin, Ireland, Jazz Pharmaceuticals, Pharma 0 Jazz Pharmaceuticals is licensing rights to a Werewolf Therapeutics cytokine therapy that’s on track to reach clinical testing next year. The deal gives Jazz a drug candidate that expands the company’s scope to immuno-oncology.